Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo-Reference-Cited by-同舟云学术

Tumor-targeted IL-12 combined with local irradiation leads to systemic tumor control via abscopal effects in vivo

Published:2017-06-03 Issue:6 Volume:6 Page:
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Eckert Franziska¹,Jelas Ivan¹^ORCID,Oehme Moritz²,Huber Stephan M.¹,Sonntag Katja²,Welker Christian²,Gillies Stephen D.³^ORCID,Strittmatter Wolfgang⁴,Zips Daniel¹,Handgretinger Rupert²,Schilbach Karin²

Affiliation:

1. Department of Radiation Oncology, Eberhard Karls University Tübingen, Tübingen, Germany

2. Department of General Pediatrics, Oncology/Hematology, Eberhard Karls University Tübingen, Tübingen, Germany

3. Provenance Biopharmaceuticals, Carlisle, MA, USA

4. Merck Serono R&D, Global Early Development, Darmstadt, Germany

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2017.1323161

Reference67 articles.

1. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

2. Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma

3. Nivolumab in Previously Untreated Melanoma withoutBRAFMutation

4. Immunotherapy for non-small-cell lung cancer: the past 10 years

5. Beyond the Immune Suppression: The Immunotherapy in Prostate Cancer

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Homing Antibody-Cytokine Fusions for Cancer Therapy;OncoTargets and Therapy;2024-08

2. Fate control engagement augments NK cell responses in LV/hu-IL-12 transduced sarcoma;Experimental and Molecular Pathology;2024-06

3. Interleukin-12 in multimodal tumor therapies for induction of anti-tumor immunity;Discover Oncology;2024-05-16

4. Common predictors of cervical cancer related mortality in Ethiopia. A systematic review and meta-analysis;BMC Public Health;2024-03-19

5. Preclinical and clinical studies of a tumor targeting IL-12 immunocytokine;Frontiers in Oncology;2024-01-08